Viewing StudyNCT00992745



Ignite Creation Date: 2024-05-05 @ 9:55 PM
Last Modification Date: 2024-10-26 @ 10:11 AM
Study NCT ID: NCT00992745
Status: COMPLETED
Last Update Posted: 2011-10-12
First Post: 2009-10-08

Brief Title: A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer
Sponsor: Molecular Insight Pharmaceuticals Inc
Organization: Molecular Insight Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
ProstaScint View
prostate cancer View
imaging View
metastases View
PSMA View